Pictet Asset Management (UK)’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $84.2M | Buy |
|
|||||
|
2021
Q1 | $88.8M | Sell |
|
|||||
|
2020
Q4 | $101M | Buy |
|
|||||
|
2020
Q3 | $82.7M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $13.3M | Buy |
|
|||||
|
2018
Q4 | $12.3K | Sell |
|
|||||
|
2018
Q3 | $24.1M | Sell |
|
|||||
|
2018
Q2 | $24.1M | Sell |
|
|||||
|
2018
Q1 | $20.2M | Buy |
|
|||||
|
2017
Q4 | $20.8M | Sell |
|
|||||
|
2017
Q3 | $23.5M | Sell |
|
|||||
|
2017
Q2 | $16.9M | Buy |
|
|||||
|
2017
Q1 | $17.2M | Buy |
|
|||||
|
2016
Q4 | $13.4M | Buy |
|
|||||
|
2016
Q3 | $17M | Sell |
|
|||||
|
2016
Q2 | $24.9M | Buy |
|
|||||
|
2016
Q1 | $2.18M | Hold |
|
|||||
|
2015
Q4 | $4.2M | Buy |
|
|||||
|
2015
Q3 | $1.54M | Buy |
|
|||||
|
2015
Q2 | $1.64M | Buy |
|
|||||
|
2015
Q1 | $1.43M | Sell |
|
|||||
|
2014
Q4 | $4.53M | Buy |
|
|||||
|
2014
Q3 | $1.38M | Buy |
|
|||||
|
2014
Q2 | $1.31M | Buy |
|